Global Animal Therapeutics and Diagnostics 麻豆原创 Research Report 2024

Publication ID:

PB501245407

Publication Date:

January 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Diagnostic instruments aid in the determination of causative agents of diseases.听
The global Animal Therapeutics and Diagnostics market was valued at US$ 36650 million in 2023 and is anticipated to reach US$ 43500 million by 2030, witnessing a CAGR of 2.0% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 17%.
This report aims to provide a comprehensive presentation of the global market for Animal Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Therapeutics and Diagnostics.
Report Scope
The Animal Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Bayer
Eli Lilly
Boehringer Ingelheim
Merck
Zoetis
Ceva Sant茅 Animale
Sanofi
Nutreco
Virbac
IDEXX Laboratories
Segment by Type
Animal Diagnostics Products
Animal Therapeutics Products
Segment by Application
Companion Animals
Ruminants
Poultry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Therapeutics and Diagnostics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Animal Therapeutics and Diagnostics 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Animal Diagnostics Products
1.2.3 Animal Therapeutics Products
1.3 麻豆原创 by Application
1.3.1 Global Animal Therapeutics and Diagnostics 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Companion Animals
1.3.3 Ruminants
1.3.4 Poultry
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Therapeutics and Diagnostics 麻豆原创 Perspective (2019-2030)
2.2 Animal Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Animal Therapeutics and Diagnostics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Animal Therapeutics and Diagnostics Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Animal Therapeutics and Diagnostics Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Animal Therapeutics and Diagnostics 麻豆原创 Dynamics
2.3.1 Animal Therapeutics and Diagnostics Industry Trends
2.3.2 Animal Therapeutics and Diagnostics 麻豆原创 Drivers
2.3.3 Animal Therapeutics and Diagnostics 麻豆原创 Challenges
2.3.4 Animal Therapeutics and Diagnostics 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Animal Therapeutics and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Animal Therapeutics and Diagnostics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Animal Therapeutics and Diagnostics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Therapeutics and Diagnostics Revenue
3.4 Global Animal Therapeutics and Diagnostics 麻豆原创 Concentration Ratio
3.4.1 Global Animal Therapeutics and Diagnostics 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Therapeutics and Diagnostics Revenue in 2023
3.5 Animal Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Animal Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Animal Therapeutics and Diagnostics 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Animal Therapeutics and Diagnostics Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Animal Therapeutics and Diagnostics Forecasted 麻豆原创 Size by Type (2025-2030)
5 Animal Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Animal Therapeutics and Diagnostics Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Animal Therapeutics and Diagnostics Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Animal Therapeutics and Diagnostics 麻豆原创 Size (2019-2030)
6.2 North America Animal Therapeutics and Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2019-2024)
6.4 North America Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Therapeutics and Diagnostics 麻豆原创 Size (2019-2030)
7.2 Europe Animal Therapeutics and Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2019-2024)
7.4 Europe Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Therapeutics and Diagnostics 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Animal Therapeutics and Diagnostics 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Animal Therapeutics and Diagnostics 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Animal Therapeutics and Diagnostics 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Therapeutics and Diagnostics 麻豆原创 Size (2019-2030)
9.2 Latin America Animal Therapeutics and Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Therapeutics and Diagnostics 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Animal Therapeutics and Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Animal Therapeutics and Diagnostics 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Animal Therapeutics and Diagnostics Introduction
11.1.4 Bayer Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Animal Therapeutics and Diagnostics Introduction
11.2.4 Eli Lilly Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.2.5 Eli Lilly Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Animal Therapeutics and Diagnostics Introduction
11.3.4 Boehringer Ingelheim Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Animal Therapeutics and Diagnostics Introduction
11.5.4 Merck Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Zoetis
11.6.1 Zoetis Company Detail
11.6.2 Zoetis Business Overview
11.6.3 Zoetis Animal Therapeutics and Diagnostics Introduction
11.6.4 Zoetis Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.6.5 Zoetis Recent Development
11.7 Ceva Sant茅 Animale
11.7.1 Ceva Sant茅 Animale Company Detail
11.7.2 Ceva Sant茅 Animale Business Overview
11.7.3 Ceva Sant茅 Animale Animal Therapeutics and Diagnostics Introduction
11.7.4 Ceva Sant茅 Animale Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.7.5 Ceva Sant茅 Animale Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Animal Therapeutics and Diagnostics Introduction
11.8.4 Sanofi Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Nutreco
11.9.1 Nutreco Company Detail
11.9.2 Nutreco Business Overview
11.9.3 Nutreco Animal Therapeutics and Diagnostics Introduction
11.9.4 Nutreco Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.9.5 Nutreco Recent Development
11.10 Virbac
11.10.1 Virbac Company Detail
11.10.2 Virbac Business Overview
11.10.3 Virbac Animal Therapeutics and Diagnostics Introduction
11.10.4 Virbac Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.10.5 Virbac Recent Development
11.11 IDEXX Laboratories
11.11.1 IDEXX Laboratories Company Detail
11.11.2 IDEXX Laboratories Business Overview
11.11.3 IDEXX Laboratories Animal Therapeutics and Diagnostics Introduction
11.11.4 IDEXX Laboratories Revenue in Animal Therapeutics and Diagnostics Business (2019-2024)
11.11.5 IDEXX Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Bayer
Eli Lilly
Boehringer Ingelheim

Merck
Zoetis
Ceva Sant茅 Animale
Sanofi
Nutreco
Virbac

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.